153 related articles for article (PubMed ID: 30630402)
21. Pharmacological and psychosocial treatment of depression in primary care: Low intensity and poor adherence and continuity.
Vuorilehto MS; Melartin TK; Riihimäki K; Isometsä ET
J Affect Disord; 2016 Sep; 202():145-52. PubMed ID: 27262636
[TBL] [Abstract][Full Text] [Related]
22. Psychodramatic psychotherapy combined with pharmacotherapy in major depressive disorder: an open and naturalistic study.
Costa EM; Antonio R; Soares MB; Moreno RA
Braz J Psychiatry; 2006 Mar; 28(1):40-3. PubMed ID: 16612489
[TBL] [Abstract][Full Text] [Related]
23. The clinical, psychosocial, and pharmacoeconomic ramifications of remission.
Thase ME
Am J Manag Care; 2001 Sep; 7(11 Suppl):S377-85. PubMed ID: 11570028
[TBL] [Abstract][Full Text] [Related]
24. Usual Care for Adolescent Depression From Symptom Identification Through Treatment Initiation.
O'Connor BC; Lewandowski RE; Rodriguez S; Tinoco A; Gardner W; Hoagwood K; Scholle SH
JAMA Pediatr; 2016 Apr; 170(4):373-80. PubMed ID: 26832387
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
Gukasyan N; Davis AK; Barrett FS; Cosimano MP; Sepeda ND; Johnson MW; Griffiths RR
J Psychopharmacol; 2022 Feb; 36(2):151-158. PubMed ID: 35166158
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of combined therapy and pharmacotherapy for depressed patients with or without personality disorders.
Kool S; Dekker J; Duijsens IJ; de Jonghe F; Puite B
Harv Rev Psychiatry; 2003; 11(3):133-41. PubMed ID: 12893503
[TBL] [Abstract][Full Text] [Related]
27. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
Nau DP; Chao J; Aikens JE
Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
[TBL] [Abstract][Full Text] [Related]
28. Combining psychotherapy and antidepressants in the treatment of depression.
de Jonghe F; Kool S; van Aalst G; Dekker J; Peen J
J Affect Disord; 2001 May; 64(2-3):217-29. PubMed ID: 11313088
[TBL] [Abstract][Full Text] [Related]
29. Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literature.
Cosci F; Mansueto G; Fava GA
Int J Psychiatry Clin Pract; 2020 Nov; 24(4):341-348. PubMed ID: 32716222
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis.
Guidi J; Fava GA; Fava M; Papakostas GI
Psychol Med; 2011 Feb; 41(2):321-31. PubMed ID: 20444307
[TBL] [Abstract][Full Text] [Related]
31. Collaborative management to achieve treatment guidelines. Impact on depression in primary care.
Katon W; Von Korff M; Lin E; Walker E; Simon GE; Bush T; Robinson P; Russo J
JAMA; 1995 Apr; 273(13):1026-31. PubMed ID: 7897786
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
33. Effect of mental health specialty care on antidepressant length of therapy.
Croghan TW; Melfi CA; Dobrez DG; Kniesner TJ
Med Care; 1999 Apr; 37(4 Suppl Lilly):AS20-3. PubMed ID: 10217389
[TBL] [Abstract][Full Text] [Related]
34. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
35. When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder?
Thase ME
Psychiatr Q; 1999; 70(4):333-46. PubMed ID: 10587988
[TBL] [Abstract][Full Text] [Related]
36. Emerging antidepressants to treat major depressive disorder.
Block SG; Nemeroff CB
Asian J Psychiatr; 2014 Dec; 12():7-16. PubMed ID: 25277330
[TBL] [Abstract][Full Text] [Related]
37. Continuity of antidepressant treatment for adults with depression in the United States.
Olfson M; Marcus SC; Tedeschi M; Wan GJ
Am J Psychiatry; 2006 Jan; 163(1):101-8. PubMed ID: 16390896
[TBL] [Abstract][Full Text] [Related]
38. Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials.
Karyotaki E; Tordrup D; Buntrock C; Bertollini R; Cuijpers P
Epidemiol Psychiatr Sci; 2017 Oct; 26(5):501-516. PubMed ID: 27328966
[TBL] [Abstract][Full Text] [Related]
39. Mental health treatment dose and annual healthcare costs in patients with cancer and major depressive disorder.
Mausbach BT; Bos T; Irwin SA
Health Psychol; 2018 Nov; 37(11):1035-1040. PubMed ID: 30265046
[TBL] [Abstract][Full Text] [Related]
40. Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants.
Rosso G; Aragno E; Cuomo A; Fagiolini A; Di Salvo G; Maina G
Psychiatry Res; 2019 May; 275():27-30. PubMed ID: 30878853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
